Nyxoah SA (5YI)
FSX
Real-time Data
06:00 AM
Day's Range
1.4952 wk Range
1.22Overview - 5YI - Nyxoah SA
Key Statistics
Valuation
Enterprise Value
91.49M
P/E (Trailing)
‪-0.53‬
P/E (Forward)
‪-0.88‬
PEG Ratio
‪-0.11‬
Price / Sales (TTM)
‪5.89‬
Price / Book
‪1.53‬
EV / EBITDA
‪-1.10‬
Profitability
Gross Margin
‪59.72%‬
Profit Margin
‪63.13%‬
Operating Margin
‪-268.24%‬
Return on Assets
‪-36.86%‬
Return on Equity
‪-122.68%‬
Ownership
Shares Outstanding
100.07M
Float
50.88M
Held by Insiders
‪33.19%‬
Held by Institutions
‪29.90%‬
Price stats
Beta
‪0.94‬
50-Day Avg
‪1.28‬
200-Day Avg
‪2.74‬
Dividends
Payout Ratio
‪0.00%‬
Peers - 5YI - Nyxoah SA
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on FSX.
Profile Summary - 5YI - Nyxoah SA
About
Nyxoah SA is a medical technology company specializing in the development and commercialization of innovative solutions for treating obstructive sleep apnea (OSA). Its flagship product, the Genio system, offers a CE-marked, patient-centric, minimally invasive hypoglossal neurostimulation therapy designed for moderate…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
